Cytocom, Inc.
CBLI · NASDAQ
6/30/2021 | 3/31/2021 | 12/31/2020 | 9/30/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$660 | -$538 | -$695 | -$745 |
| Dep. & Amort. | $1 | $2 | $3 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$11,429 | $12,166 | -$731 | -$542 |
| Other Non-Cash | $11,227 | -$11,993 | $635 | $588 |
| Operating Cash Flow | -$860 | -$363 | -$788 | -$683 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$326 | $7 |
| Inv. Sales/Matur. | $269 | $54 | $339 | -$8 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $269 | $54 | $13 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $12,723 | $0 | $2,783 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $12,723 | $0 | $2,783 |
| Financing Cash Flow | $0 | $12,723 | $0 | $2,783 |
| Forex Effect | $9 | -$1 | $1 | -$5 |
| Net Chg. in Cash | -$582 | $12,413 | -$775 | -$688 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,359 | $1,946 | $2,721 | $3,409 |
| End Cash | $13,777 | $14,359 | $1,946 | $2,721 |
| Free Cash Flow | -$860 | -$363 | -$788 | -$683 |